Prevalence of infections in intensive care units in Mexico:: A multicenter study

被引:72
作者
de León-Rosales, SP
Molinar-Ramos, F
Domínguez-Cherit, G
Rangel-Frausto, MS
Vázquez-Ramos, VG
机构
[1] Inst Nacl Nutr Salvador Zubiran, Div Hosp Epidemiol, Tlalpan 14000, DF, Mexico
[2] Inst Nacl Nutr Salvador Zubiran, Intens Care Unit, Tlalpan 14000, DF, Mexico
[3] Ctr Med Nacl La Raza, Intens Care Unit, Mexico City, DF, Mexico
[4] Hoechst Marion Roussel, Dept Med, Mexico City, DF, Mexico
关键词
sepsis; intensive care unit; nosocomial infection; mortality rates; bacteremia; risk factor;
D O I
10.1097/00003246-200005000-00010
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To determine the 1-day prevalence of community-acquired,hospital-acquired, or intensive care unit (ICU)-acquired infections in Mexican ICUs. To identify associated risk factors, predominant infecting organisms, and mortality rates. Design: A 1-day point-prevalence study. Setting: A total of 254 adult ICUs in Mexico. Patients: Adult patients hospitalized in the participating ICUs. Results: A total of 895 patients were studied, of whom 521 patients (58.2%) were infected. community-acquired infection occurred in 214 patients (23.9%), non-ICU nosocomial infection occurred in 99 patients (11.1%), and 208 patients had at least one ICU-acquired infection (23.2%; 1.45 episodes/patient). The most frequently reported ICU-acquired infections were pneumonia (39.7%), urinary tract infections (20.5%), wound infection (13.3%), and bacteremia (7.3%). The mortality rate for the ICU-acquired infections after 6 wks of follow-up was 25.5%. Multivariate regression analysis showed the following risk factors for ICU-acquired infections: neurologic failure as a primary cause of admission (odds ratio [OR], 1.697; 95% confidence interval [GI], 1.001-2.839); length of stay in ICU (OR, 1.119; 95% CI, 1.091-1.151); number of therapeutic and/or diagnostic interventions during the preceding week (OR, 1.118; 95% CI, 1.016-1.231); peripherally administered infusion of hyperosmolar solutions (OR, 6.93; 95% CI, 2.452-21.661); sedative usage in the preceding week (OR, 1.751; 95% CI, 1.183-2.602); history of an emergency surgery in the preceding month (OR, 1.875; 95% CI, 1.251-2.813). The administration of antimicrobial treatment if there was an infection decreased the risk of death (OR, 0.406; 95% CI, 0.204-0.755). Conclusions: Evidence of a high frequency of nosocomial infections was found, and potential risk factors for acquiring infections and mortality were identified. Mortality rates according to the hierarchy of the systemic inflammatory response syndrome in Latin American ICUs are reported.
引用
收藏
页码:1316 / 1321
页数:6
相关论文
共 19 条
  • [1] BANERJEE SN, 1991, AM J MED S3B, V91, P86
  • [2] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [3] CALVIN JE, 1995, CRITICAL CARE MED PR, P1431
  • [4] NOSOCOMIAL INFECTION AND FATALITY IN MEDICAL AND SURGICAL INTENSIVE-CARE UNIT PATIENTS
    CRAVEN, DE
    KUNCHES, LM
    LICHTENBERG, DA
    KOLLISCH, NR
    BARRY, MA
    HEEREN, TC
    MCCABE, WR
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (05) : 1161 - 1168
  • [5] DELEON RSP, 1992, DESARROLLO FORTALECI, P178
  • [6] DELEON SP, 1986, SAL PUB MEX, V28, P111
  • [7] CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988
    GARNER, JS
    JARVIS, WR
    EMORI, TG
    HORAN, TC
    HUGHES, JM
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) : 128 - 140
  • [8] THE EFFICACY OF INFECTION SURVEILLANCE AND CONTROL PROGRAMS IN PREVENTING NOSOCOMIAL INFECTIONS IN UNITED-STATES HOSPITALS
    HALEY, RW
    CULVER, DH
    WHITE, JW
    MORGAN, WM
    EMORI, TG
    MUNN, VP
    HOOTON, TM
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1985, 121 (02) : 182 - 205
  • [9] APACHE-II - A SEVERITY OF DISEASE CLASSIFICATION-SYSTEM
    KNAUS, WA
    DRAPER, EA
    WAGNER, DP
    ZIMMERMAN, JE
    [J]. CRITICAL CARE MEDICINE, 1985, 13 (10) : 818 - 829
  • [10] LORIAN V, 1995, INFECT CONT HOSP EP, V16, P638